Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Advanced Gastric Cancer
Interventions: Procedure: laparoscopy assisted distal gastrectomy; Procedure: open distal gastrectomy
Sponsor: National Cancer Center, Korea
Not yet recruiting - verified March 2010
Condition: Lymphoma
Interventions: Drug: cyclophosphamide; Drug: prednisolone; Drug: vinblastine; Other: watchful waiting; Procedure: therapeutic conventional surgery
Sponsor: Martin-Luther-Universität Halle-Wittenberg
Recruiting - verified March 2010
Conditions: Parathyroid Adenoma; Thyroid Adenoma
Intervention:
Sponsor: Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified March 2010
Conditions: Focal Brain Lesion; Focal Lesions; fMRI
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Condition: Melanoma (Skin)
Interventions: Biological: HLA-A1-binding MAGE-1/MAGE-3 multipeptide-pulsed autologous dendritic cell vaccine; Biological: HLA-A2-binding TYR/MART-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine; Biological: autologous melanoma lysate-pulsed autologous dendritic cell vaccine; Biological: autologous melanoma lysate/tracer antigen KLH-pulsed autologous dendritic cell vaccine; Biological: dendritic cell-idiotype-keyhole limpet hemocyanin vaccine; Other: flow cytometry; Procedure: adjuvant therapy
Sponsor: Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
Recruiting - verified March 2010
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: telaprevir; Drug: VX-222; Drug: ribavirin; Biological: peginterferon-alfa-2a; Drug: VX-222
Sponsor: Vertex Pharmaceuticals Incorporated
Not yet recruiting - verified March 2010
Condition: Lung Cancer
Intervention: Other: VB software
Sponsors: VU University Medical Center; Philips Healthcare
Not yet recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Drug: Neoadjuvant Hormonal Therapy; Drug: Docetaxel
Sponsor: M.D. Anderson Cancer Center
Active, not recruiting - verified February 2010
Condition: Bladder Cancer
Interventions: Procedure: open radical cystectomy; Procedure: robotic-assisted radical cystectomy
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified February 2010
Condition: Hematologic Malignancies
Intervention: Other: TOTAL LYMPHOID IRRADIATION
Sponsor: Fondazione Neoplasie Sangue Onlus
Recruiting - verified March 2010
Condition: Prostatic Neoplasm
Intervention: Drug: leuprolide (Lucrin/Lucrin-Tri-depot)
Sponsor: Abbott
Active, not recruiting - verified March 2010
Condition: PROSTATE CANCER.
Interventions: Drug: Docetaxel and Prednisone; Drug: Docetaxel and Prednisone; Drug: Radiation Therapy
Sponsors: Northwestern University; Genzyme
Not yet recruiting - verified March 2010
Conditions: Squamous Cell Carcinoma of the Oral Cavity; Oropharynx Metastases; Lymph Metastases
Interventions: Procedure: endoscopic examination; Procedure: FDG-PET
Sponsor: University Hospital, Ghent
Recruiting - verified March 2010
Condition: Advanced Nasopharyngeal Cancer
Interventions: Drug: Nimotuzumab; Radiation: radiotherapy; Drug: cisplatin
Sponsor: Biotech Pharmaceutical Co.,LTD
Recruiting - verified September 2009
Condition: Thyroid Cancer
Intervention:
Sponsor: National Cancer Institute, Naples
Recruiting - verified February 2010
Condition: Food Allergy
Intervention:
Sponsor: University of Erlangen-Nürnberg Medical School
Not yet recruiting - verified February 2010
Condition: Hypertension
Interventions: Drug: Non-ARB (standard therapy); Drug: ARB (Telmisartan)
Sponsor: Kumamoto University
Recruiting - verified June 2009
All Categories ... by Company » ... Vertex Pharma 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
